3-iodobenzylguanidine has been researched along with Impotence in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capoluongo, E; Defeudis, G; Fioriti, E; Manfrini, S; Minucci, A; Palermo, A; Pozzilli, P; Tuccinardi, D | 1 |
Berg, D; Postuma, RB | 1 |
1 review(s) available for 3-iodobenzylguanidine and Impotence
Article | Year |
---|---|
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
1 other study(ies) available for 3-iodobenzylguanidine and Impotence
Article | Year |
---|---|
A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Erectile Dysfunction; Genetic Testing; Humans; Male; Middle Aged; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Tomography, X-Ray Computed; Von Hippel-Lindau Tumor Suppressor Protein | 2018 |